Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01752465
What this trial is testing

Is Health Coaching Effective for Improving Metabolic Health in People With Psychosis Disorders?

Who this might be right for
Psychotic DisordersMetabolic Syndrome x
University of British Columbia 40
Post-approval studies (Phase 4)WithdrawnNCT06107829
What this trial is testing

Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities

Who this might be right for
Tardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities
Stephen Ruedrich
Early research (Phase 1)Study completedNCT01552772
What this trial is testing

Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 60
Large-scale testing (Phase 3)Study completedNCT00590577
What this trial is testing

Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 652
Not applicableEnded earlyNCT01420575
What this trial is testing

Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
VA Nebraska Western Iowa Health Care System 8
Early research (Phase 1)Study completedNCT02079844
What this trial is testing

Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia

Who this might be right for
Schizophrenia
Takeda 20
Not applicableStudy completedNCT00857064
What this trial is testing

Subjective Well Being of Schizophrenic Patients in Greece

Who this might be right for
Schizophrenia
AstraZeneca 600
Not applicableUnknownNCT04395326
What this trial is testing

Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population

Who this might be right for
Adverse Drug Event
St. Justine's Hospital 120
Not applicableStudy completedNCT03448575
What this trial is testing

Safer Use of Antipsychotics in Youth

Who this might be right for
Child Behavior Disorders
Kaiser Permanente 733
Large-scale testing (Phase 3)Study completedNCT00044681
What this trial is testing

The Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression

Who this might be right for
Depressive DisorderDepressive Disorder, MajorDepression
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 258
Post-approval studies (Phase 4)Study completedNCT02697045
What this trial is testing

Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch

Who this might be right for
Schizophrenia
Abdi İbrahim Otsuka 23
Not applicableEnrolling By InvitationNCT05165316
What this trial is testing

European Long-acting Antipsychotics in Schizophrenia Trial-II

Who this might be right for
Schizophrenia
Rene Kahn 400
Not applicableStudy completedNCT03865719
What this trial is testing

Weight Management Intervention for Youth and Young Adults With Autism Spectrum Disorder

Who this might be right for
Autism Spectrum Disorder
University of Pittsburgh 10
Not applicableStudy completedNCT03663465
What this trial is testing

The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics

Who this might be right for
Schizophrenia
Calo Psychiatric Center 135
Large-scale testing (Phase 3)Study completedNCT00236587
What this trial is testing

A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 100
Post-approval studies (Phase 4)Ended earlyNCT00418873
What this trial is testing

Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward

Who this might be right for
Schizophrenia
Astellas Pharma Inc 39
Early research (Phase 1)Study completedNCT05321602
What this trial is testing

Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic DisordersMood Disorders+9 more
Luye Pharma Group Ltd. 89
Not applicableStudy completedNCT00161031
What this trial is testing

Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 30
Not applicableEnded earlyNCT03471013
What this trial is testing

Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia

Who this might be right for
DSM-5 Schizophrenia
University Hospital, Clermont-Ferrand 50
Not applicableStudy completedNCT04312503
What this trial is testing

Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"

Who this might be right for
Schizophrenia
Aziende Chimiche Riunite Angelini Francesco S.p.A 95
Next Page